4//SEC Filing
Ingalls Kerry D. 4
Accession 0001209191-21-065673
CIK 0001661460other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 9:12 PM ET
Size
4.6 KB
Accession
0001209191-21-065673
Insider Transaction Report
Form 4
Ingalls Kerry D.
Chief Operating Officer
Transactions
- Purchase
Common Stock
2021-11-17$7.00/sh+2,000$14,000→ 2,000 total
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001816804
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 9:12 PM ET
- Size
- 4.6 KB